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Background: The sarcoplasmic reticulum Ca2+-ATPase (SERCA2) pump is an
important component of the Ca2+-clock pacemaker mechanism that provides
robustness and flexibility to sinus node pacemaking. We have developed transgenic
mice with reduced cardiac SERCA2 abundance (Serca2 KO) as a model for investigating
SERCA2’s role in sinus node pacemaking.
Methods and Results: In Serca2 KO mice, ventricular SERCA2a protein content
measured by Western blotting was 75% (P < 0.05) lower than that in control mice
(Serca2 FF) tissue. Immunofluorescent labeling of SERCA2a in ventricular, atrial, sinus
node periphery and center tissue sections revealed 46, 45, 55, and 34% (all P < 0.05
vs. Serca2 FF) lower labeling, respectively and a mosaic pattern of expression. With
telemetric ECG surveillance, we observed no difference in basal heart rate, but the
PR-interval was prolonged in Serca2 KO mice: 49 ± 1 vs. 40 ± 1 ms (P < 0.001) in
Serca2 FF. During exercise, heart rate in Serca2 KOmice was elevated to 667 ± 22 bpm,
considerably less than 780 ± 17 bpm (P < 0.01) in Serca2 FF. In isolated sinus node
preparations, 2 mM Cs+ caused bradycardia that was equally pronounced in Serca2 KO
and Serca2 FF (32 ± 4% vs. 29 ± 5%), indicating no change in the pacemaker current,
If. Disabling the Ca
2+-clock with 2 µM ryanodine induced bradycardia that was less
pronounced in Serca2 KO preparations (9 ± 1% vs. 20 ± 3% in Serca2 FF; P < 0.05),
suggesting a disrupted Ca2+-clock. Mathematical modeling was used to dissect the
effects of membrane- and Ca2+-clock components on Serca2 KO mouse heart rate and
sinus node action potential. Computer modeling predicted a slowing of heart rate with
SERCA2 downregulation and the heart rate slowing was pronounced at >70% reduction
in SERCA2 activity.
Conclusions: Serca2 KO mice show a disrupted Ca2+-clock-dependent pacemaker
mechanism contributing to impaired sinus node and atrioventricular node function.
Keywords: sinus node, atrioventricular node, Ca2+-clock, SERCA2, heart failure, telemetry, heart rate,
mathematical model
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INTRODUCTION
The sinus node is the dominant pacemaker of the heart, aptly
placed in the roof of the right atrium. It consists of specialized
pacemaker cells that spontaneously depolarize during diastole
and rhythmically generate action potentials (Keith and Flack,
1907; Silverman et al., 2006; Dobrzynski et al., 2007). The
diastolic depolarization results from the synergistic interaction
between an ensemble of surface membrane ion channel currents
and intracellular Ca2+ release signals. Together, they regulate the
rate and rhythm of the spontaneous action potentials in the sinus
node (Figure 1; Dobrzynski et al., 2007; Lakatta et al., 2010). The
voltage- and time-dependent gating of the surface membrane
channels works in a cyclic fashion (the membrane voltage-clock)
and underlies the early phase of the diastolic depolarization.
This phase involves a voltage-dependent deactivation of outward
currents and activation of inward currents (Dobrzynski et al.,
2013). The hyperpolarization-activated cyclic nucleotide-gated
(HCN) or funny current (If) is the main inward current, and
thus a vital component of the voltage-clock and essential to
pacemaking in the sinus node. Mice with a cardiac specific
conditional knockout (KO) of the HCN4 channel have reduced If
in sinus node cardiomyocytes and exhibit severe bradycardia (up
to 50% reduction in heart rate; Baruscotti et al., 2011). Similarly,
humans with HCN4 gene mutations exhibit sinus bradycardia
(Dobrzynski et al., 2013).
In contrast to the early phase, the latter phase of the diastolic
depolarization in sinus node pacemaking cells depends on
localized, sarcoplasmic reticulum-generated, intracellular Ca2+
release via the ryanodine receptor, referred to as the intracellular
Ca2+-clock. The released Ca2+ activates inward Na+-Ca2+
exchange, generating an inward current (INaCa) by exchanging
one Ca2+ for three Na+ (Figure 1; Bogdanov et al., 2006).
Acute inhibition of INaCa is reported to stop pacemaking in
single rabbit sinus node myocytes (Bogdanov et al., 2001).
The localized release of Ca2+ from the sarcoplasmic reticulum
is dependent upon the sarcoplasmic reticulum Ca2+-load
which is regulated by the sarcoplasmic reticulum Ca2+-ATPase
(SERCA) pump (Vinogradova et al., 2010). Inhibition of SERCA2
with cyclopiazonic acid induces a concentration-dependent
suppression of spontaneous sinus node myocyte firing rate by up
to 50% (Vinogradova et al., 2010; Yaniv et al., 2014).
We hypothesized that reduced Serca2 in the sinus node
disrupts the Ca2+-clock component of pacemaking and
contributes to pacemaker dysfunction. This hypothesis was
tested in a Serca2 conditional KO mouse model in which cardiac
specific Serca2 excision can be induced at any age by exposure to
tamoxifen.
METHODS
Homozygous, conditional cardiac specific Serca2 KO and
age-matched control (Serca2 FF) mice were studied. Mice
with Serca2 downregulation in the heart were generated
using the Cre-lox system conditional gene KO strategy as
described previously by Andersson et al. (2009). At 12 weeks
of age, male Serca2 KO (Serca2flox/flox Tg(αMHC-MerCreMer);
FIGURE 1 | Schematic illustration of pacemaker mechanisms in the
sinus node myocyte. Sinus node action potential is preceded by a slow
diastolic depolarization (DD) which brings the membrane potential up to the
threshold level for excitation. The DD is a result of synergistic interaction
between the membrane voltage-clock and the subcellular Ca2+-clock. The
membrane voltage-clock comprises plasma membrane bound,
voltage-dependent ion channels and their corresponding ionic currents. At the
beginning of the DD, there is voltage-dependent deactivation of outward K+
currents (IK,r and IK,s) and activation of inward currents:
hyperpolarization-activated cyclic nucleotide-gated (HCN) or funny current (If ),
T-type Ca2+ current (ICa,T ) and L-type Ca
2+ current (ICa,L ) amongst others.
The Ca2+-clock contributes to sinus node DD through localized Ca2+ release
from the sarcoplasmic reticulum via the ryanodine receptor (RYR2). Increased
levels of cytosolic Ca2+ activates the electrogenic Na+–Ca2+ exchanger
(NCX1) generating an inward current (INaCa) that imparts a steep, exponential
increase to the late phase of DD. SERCA2 refills the sarcoplasmic reticulum
with Ca2+ and is hence crucial to sinus node pacemaking.
n = 22) and control (Serca2flox/flox; FF, n = 20) mice
were injected with 1mg of tamoxifen intraperitoneally to
induce Serca2 excision in cardiomyocytes. All experiments
were carried out 7 weeks after tamoxifen administration
in accordance with the Norwegian National Committee for
Animal Welfare Act, consistent with the NIH guidelines (NIH
publication No. 85-23, revised 1996). SERCA2a abundance and
expression pattern was investigated by Western blotting and
immunohistochemistry (n = 10). Telemetry transmitters were
implanted in one cohort of mice (n = 16) as previously
described (Stokke et al., 2010). ECG was recorded under baseline
conditions, during maximal exercise, and after a subsequent i.p.
injection of adrenalin (0.5 mg/kg). In vitro electrophysiological
investigation of the sinus node was carried out by recording
extracellular potentials in isolated sinus node preparations
(n = 16). Tissue preparations of Wistar rat hearts (n =
13), with intact sinus and AV nodes were used in some
investigations.
Frontiers in Physiology | www.frontiersin.org 2 June 2016 | Volume 7 | Article 197
Logantha et al. Sinus Node in SERCA2 Knockout
Mathematical modeling of the mouse heart rate was
performed using our biophysically detailed single pacemaker
cell model of the mouse sinus node (Kharche et al., 2011).
This robustly validated model describes the mouse sinus
node electrophysiology based on a spectrum of membrane
ionic currents (membrane voltage-clock), which are coupled
to the intracellular Ca2+ dynamics (Ca2+-clock). The model
code was implemented in C programming language, and was
integrated using an implicit backward difference formula that
provided a high accuracy of O(dt5), computational efficiency and
unconditional numerical stability. The model code, including
dependencies, is available from the authors on request. Standard
library based code is available from the model repository,
ModelsDB (https://senselab.med.yale.edu/modeldb/ShowModel.
cshtml?model=141274). All data are expressed as mean ± s.e.m.
and n refers to the number of hearts. Either an unpaired t-test
or one-way ANOVA followed by Tukey’s multiple comparisons
post-test was conducted to determine significant differences.
The difference was considered to be significant when P < 0.05.
Detailed methodology is available in the SupplementaryMaterial.
RESULTS
The body weight of mice in the Serca2 FF group and Serca2 KO
group were 32 ± 2 g (n = 12) and 32 ± 3 g (n = 14), respectively
at 7 weeks after tamoxifen administration (Figure 2A).
SERCA2a Expression in the Ventricular
Myocardium
SERCA2a protein expression in the ventricular myocardium
was investigated by Western blot and immunohistochemistry.
Western blot analysis (Figure 2B) revealed that SERCA2a protein
content normalized to α-tubulin content was reduced from
4.0± 0.5 a.u. (n = 4) in Serca2 FF to 1.0 ± 0.3 a.u. (n = 6;
P < 0.05) in Serca2 KO ventricular myocardium (Figure 2C).
The distribution and expression pattern of SERCA2a protein in
ventricular myocardium was assessed by immunolabelling tissue
sections with a SERCA2a antibody (Supplement Table 1). In
ventricular myocytes, labeling occurred adjacent to the outer cell
membrane, as well as in an internal striated pattern, consistent
with earlier reports of SERCA2 protein expression in ventricular
myocytes (Musa et al., 2002). Figures 3A–D shows the typical
distribution of SERCA2a protein in ventricular cross sections
of Serca2 FF (n = 4; Figures 3A,C) and Serca2 KO (n= 6;
Figures 3B,D) mouse hearts. Similar patterns of expression
were observed in all Serca2 FF and Serca2 KO tissue sections.
At both low (Figure 3A) and high (Figure 3C) magnification,
SERCA2a expression in the Serca2 FF tissue was uniform with
all cardiomyocytes expressing the SERCA2a protein. However,
in the Serca2 KO tissue sections, expression appeared reduced,
mosaic-like and heterogeneous, i.e., some cells expressed
and some did not (Figures 3B,D). The bright red signal in
cardiomyocytes in Figures 3B,D represent ventricular myocytes
expressing SERCA2a protein in the Serca2KOheart sections. The
negative controls did not show fluorescence of any significance
(Supplement Figure 1). Quantification of immunofluorescence
FIGURE 2 | SERCA2a expression in ventricular myocardium. (A) Body
weight of Serca2 FF and Serca2 KO mice. (B) Western blots of SERCA2a
protein and α-tubulin expression in ventricular myocardium of Serca2 FF
(left; n = 4) and Serca2 KO (right; n = 6) hearts. (C) Mean values of SERCA2a
band density normalized to α-tubulin in Serca2 FF and Serca2 KO samples.
*P < 0.05 vs. Serca2 FF.
measurements showed reduction in SERCA2a protein expression
from 116 ± 4 a.u. (n = 4) in Serca2 FF to 62 ± 6 a.u. (n= 6;
P < 0.05) in Serca2 KO sections (Figure 3G). The SERCA2a
content measured by Western blot and immunohistochemistry
in the individual heart samples was plotted (Supplement Figure
2). SERCA2a protein expression measured by either of the two
techniques revealed a similar downregulation.
Connexin 43 (Cx43), a major gap junction connexin in the
heart, was labeled in adjacent ventricular tissue sections and used
as a marker of ventricular cardiomyocytes (Figures 3E,F). The
quantified immunofluorescence of Cx43 labeling was 52 ± 4 a.u.
(n= 4) in Serca2 FF and 54± 2 a.u. (n= 6) in Serca2KO sections.
The Cx43 protein expression remained unchanged (Figure 3H).
Telemetry ECG
ECG was recorded in conscious animals with the aid of
implanted telemetry electrodes (Figure 4A). The baseline heart
rate measured in freely moving Serca2 FF and Serca2 KO animals
was 536 ± 27 and 536± 31 beats per minute (bpm), respectively
(both groups n = 8, Figures 4B,C). The treadmill test was
performed as a gradual, stepwise increase in the running speed
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FIGURE 3 | Immunohistochemical detection of SERCA2a and Cx43 in
ventricular myocardium. (A–D) Representative immunofluorescence images
of SERCA2a protein labeling (red signal) in ventricular myocardium of Serca2
FF (A,C) and Serca2 KO (B,D) hearts. (E,F), high magnification images of
Cx43 expression in ventricular myocardium of Serca2 FF and Serca2 KO
hearts. (G,H) bar charts showing mean SERCA2a (G) and Cx43 (H) content in
the ventricular myocardium of Serca2 FF (blue bars; n = 4) and Serca2 KO
(red bars; n = 6) hearts. *P < 0.05 vs. Serca2 FF.
until exhaustion. Serca2 FF achieved a maximal heart rate of
780 ± 17 bpm, significantly higher than the 667 ± 22 bpm
achieved by Serca2 KO (P < 0.01 vs. Serca2 FF, Figures 4A–C).
The distance traveled till exhaustion in Serca2 FF was 117± 16m
and that in Serca2 KO was 56 ± 6m (P < 0.01). The maximum
running speed was significantly higher in Serca2 FF (18± 1 vs. 12
± 1 m/min in Serca2 KO, P < 0.05). Subsequently, animals were
injected intraperitoneally (i.p.) with adrenaline (0.5 mg/kg bw)
and at 10 min after adrenaline administration, the heart rates in
Serca2 FF and Serca2KO animals was 681± 9 and 581± 23 bpm,
respectively (P < 0.01, Figures 4A–C). The ECG PR-intervals
at baseline, during maximal exercise, and after a subsequent i.p.
injection of adrenalin in Serca2 FF was 40 ± 1, 31 ± 1, and 37 ±
2 ms and the corresponding values for Serca2 KO were 49± 1 (P
FIGURE 4 | Telemetry ECG parameters. (A) Representative records of
telemetry ECG in Serca2 FF (left) and Serca2 KO (right) mice under baseline
conditions, maximal exercise, and after a subsequent i.p. injection of
adrenaline (0.5mg/kg). (B) Heart rate measurements in freely moving Serca2
FF (blue bars) and Serca2 KO (red bars) mice during baseline conditions,
maximal exercise, and after a subsequent i.p. injection of adrenalin (0.5
mg/kg). (C) Change in heart rate during exercise and after adrenaline injection
presented as a percentage of corresponding baseline values. (D) The
PR-interval in Serca2 FF (blue bars) and Serca2 KO (red bars) mice during
baseline conditions, maximal exercise, and after adrenaline administration.
(E) Change in PR-interval presented as a percentage of corresponding
baseline values. *, **, and *** denote P < 0.05, P < 0.01, and P < 0.0001,
respectively vs. corresponding Serca2 FF.
< 0.001 vs. Serca2 FF), 37 ± 2 (P < 0.05 vs. Serca2 FF) and 51 ±
4 ms (P < 0.05 vs. Serca2 FF), respectively (Figures 4D,E).
Sarcoplasmic Reticulum Ca2+ and
Atrioventricular Node
In rat right atrial preparations, the role of sarcoplasmic reticulum
Ca2+ in sinus and atrioventricular (AV) node function was
assessed in vitro. Ryanodine (2 µM) prolonged the sinus node
intrinsic cycle length from 241.1 ± 9.63 ms (n = 13) to 369.8 ±
25.4 ms (n = 10; P < 0.001). The tissue was overdrive paced and
the atrio-His (AH) interval (a measure of conduction through
the AV node) and the AV node Wenckebach cycle length were
measured. Ryanodine (2 µM) prolonged the AH-interval from
47± 6.1 ms to 59 ± 7.7 ms (P ≤ 0.01) and the AV node
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Wenckebach cycle length from 161.5 ± 11.7 ms to 205.1 ± 22.7
ms (P ≤ 0.05).
Sinus Node Pacemaking in Serca2 KOMice
The intrinsic beating/heart rate measured in isolated sinus node
preparations at 37◦C was 415 ± 16 bpm (n = 8) in Serca2 FF
and 431 ± 30 bpm (n = 8) in Serca2 KO (Figure 5A) tissues.
The response to pharmacological block of the membrane- and
Ca2+-clock was measured by separately treating tissues with 2
mM Cs+ (for If block) and 2 µM ryanodine (for disabling Ca
2+
release via the ryanodine receptor). In the presence of Cs+, the
sinus rate reduced to 294 ± 59 bpm (n = 8) in Serca2 FF and
291± 33 bpm (n = 8) in Serca2 KO (Figure 5A) mice. The
response to ryanodine was different in Serca2 KO compared to
Serca2 FF mice. The sinus rate dropped to 323± 26 bpm (n= 7)
in Serca2 FF mice whereas in Serca2 KO mice, the drop in sinus
rate was to 377± 26 bpm (n= 7; Figures 5A,B). In other words,
the effect of ryanodine was less pronounced in Serca2 KO tissue
in comparison with Serca2 FF tissue.
SERCA2 Downregulation in Sinus Node
Histological staining with Masson’s trichrome was performed in
tissue sections that were cut perpendicular to the crista terminalis
of Serca2 FF and Serca2 KO right atrial tissue. The morphology
and architecture of the sinus node was not affected in Serca2
KO mice (data not shown). The histology images were used to
locate the sinus node and identify suitable sections for labeling
with immunofluorescent markers. HCN4was used as the positive
marker to delineate sinus node myocytes and Cx43 was used to
label atrial muscle (Liu et al., 2007). Typical low magnification
images of HCN4 and Cx43 are shown in Figure 6 (top and
middle row). Adjacent sections labeled for SERCA2a are shown
in Figure 6 (bottom row). Representative high magnification
images of the sinus node center, sinus node periphery and
atrial muscle are shown in Figure 7A. The SERCA2a expression
FIGURE 5 | Sinus node pacemaking in Serca2 FF vs. Serca2 KO mice.
(A) Change in heart rate of isolated sinus node preparations from Serca2 FF
and Serca2 KO in response to treatment with 2 mM CsCl and 2 µM ryanodine.
(B) Percentage reduction of heart rate in vitro induced by CsCl (2 mM) and
ryanodine (2 µM) treatment. The CsCl (2 mM) and ryanodine (2 µM)
measurements are presented as percentage of control and wash CsCl values,
respectively. Serca2 FF data are shown in blue and Serca2 KO data are shown
in red color. *, †, and ‡ represent P < 0.05 vs. control, wash CsCl and CsCl
(2 mM) respectively. Blue symbols are used for Serca2 FF and red for Serca2
KO data. #represents P < 0.05 vs. Serca2 KO ryanodine response (Serca2
FF, n = 8 and Serca2 KO, n = 8).
pattern in these sections was similar to that seen in sections from
the ventricular myocardium: in the Serca2 FF sinus node center,
sinus node periphery and atrial muscle, SERCA2a protein was
ubiquitously expressed in all myocytes (Figure 7A, top row). In
contrast, in the Serca2 KO sections, SERCA2a expression was
reduced and mosaic-like in all three regions (Figure 7A, bottom
row). The quantified fluorescence measurements in Serca2 FF
sections were 147 ± 14, 139 ± 10, and 110 ± 9 a.u. (n = 4) in
the sinus node center, sinus node periphery and atrial muscle,
respectively (Figure 7B). In Serca2 KO sections, fluorescence
measurements were reduced to 97 ± 12, 62 ± 9, and 60 ± 4 (n
= 6; all P < 0.05 vs. corresponding Serca2 FF values). HCN4 and
Cx43 expression patterns were similar in Serca2 FF and Serca2
KO sections (Supplement Figures 3, 4).
Mathematical Modeling of Mouse Sinus
Node Action Potential
Mathematical modeling was used to dissect the role of SERCA2
in sinus node pacemaking and to gain mechanistic insights.
The results of the simulations are presented in Figure 8. The
relationships between SERCA2 downregulation (0–99%) and
heart rate under various conditions is shown in Figure 8A.
Pacemaking in the sinus node, measured as heart rate, was
significantly more erratic at low levels of SERCA2 (99%
downregulation) than at physiological levels of SERCA2 (0%
downregulation) (red symbols, Figure 8A). At physiological
values of SERCA2, heart rate of 283 bpm was observed.
Downregulation of RyR2 channel (proportional to SERCA2
downregulation) did not affect the heart rate at 0% SERCA2
downregulation; however, it increased the arrhythmic region
at >90% SERCA2 downregulation (yellow symbols, Figure 8A).
The increase of L-type Ca2+ current (ICa,L) caused an overall
increase of heart rate at all levels of SERCA2 (blue symbols,
Figure 8A). The heart rate at 0% SERCA2 downregulation was
287 bpm. On the other hand, increasing the Na+-Ca2+ exchanger
current (INaCa) resulted in lowering of heart rate: 272 bpm at
0% SERCA2 downregulation (green symbols, Figure 8A). When
all the above alterations were implemented simultaneously to
emulate the experimental observations, i.e. enhanced Ca2+ flux
through the L-type Ca2+ channel and the Na+-Ca2+ exchanger
in Serca2 KO mouse (Andersson et al., 2009), the resultant
heart rate (black symbols, Figure 8A), was lower than in the
case without remodeling (red symbols, Figure 8A). The slope of
the remodeled heart rate curve is shown in Figure 8B. It was
observed that the slope was small for low levels of SERCA2
downregulation and numerically large at >70% downregulation.
Action potential profiles of SERCA2 only (red) and SERCA2
KO remodeled (black) at 0% SERCA2 downregulation is shown
in Figure 8C. Corresponding action potential profiles at 0, 70,
and 99% SERCA2 downregulation are shown in Figure 8D.
Without any remodeling, beating/heart rates measured at 0
and 70% SERCA2 downregulation were 283 bpm (red solid
line, Figure 8D) and 275 bpm (red dashed line, Figure 8D)
respectively; however, at 99% downregulation the beating/heart
rate was substantially reduced to 220 bpm (red dotted line,
Figure 8D) and the region with >95% SERCA2 downregulation
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FIGURE 6 | Immunolabelling of HCN4, Cx43, and SERCA2 in right atrial sections from Serca2 FF and Serca2 KO hearts. Top row, right atrial sections from
Serca2 FF (left) and Serca2 KO (right) hearts showing HCN4 labeling (green signal) in the sinus node periphery (SAN P) and center (SAN C). Middle row, connexin 43
(Cx43) labeling (green signal) in the right atrium. Bottom row, right atrial sections showing SERCA2a labeling (green signal) throughout the tissue section in Serca2 FF
(left) and a mosaic pattern of SERCA2a labeling in Serca2 KO (right). Abbreviations: CT, crista terminalis; SAN P, sinus node periphery; SAN C, sinus node center.
was arrhythmic. Under remodeled conditions, the corresponding
heart rates were 276 bpm (black solid line, Figure 8D), 256
bpm (black dashed line, Figure 8D) and 220 bpm (black dotted
line, Figure 8D) respectively. In the remodeled case at 99%
SERCA2 downregulation, the maximum diastolic potential was
less negative (by ∼3 mV), the action potential upstroke was
biphasic and the heart rate was substantially bradycardic (black
dotted line, Figure 8D).
DISCUSSION
We have investigated the consequence of substantial Serca2
downregulation on the sinus node of the adult mouse heart.
Cardiomyocyte-specific excision of Serca2 in adult mice resulted
in reduced SERCA2a protein abundance in the sinus node,
atrial muscle and ventricular muscle. In vivo, baseline heart
rate was not affected; however, during exercise and in the
presence of adrenaline, heart rate was lower than Serca2
FF. In vitro, the intrinsic sinus node beating rate remained
unaltered in Serca2 KO. Separate assessment of the voltage- and
Ca2+-clock components of sinus node pacemaking revealed
an unaltered voltage-clock and a diminished Ca2+-clock.
Our Serca2 KO mouse model provides novel information
on the importance of SERCA2a, and thus the sarcoplasmic
reticulum Ca2+ clock, in the sinus node pacemaking
mechanism.
In our study, we have demonstrated that SERCA2a
downregulation in the sinus node of the adult mouse heart
can be achieved by relying on the α-MHC promoter to drive
the expression of the Cre-recombinase enzyme to cause cardiac
specific Serca2 deletion. The reduction in SERCA2a protein
content occurs in the sinus node, as well as atrial and ventricular
tissues, suggesting Cre expression in all of these tissues. α-MHC
is a contractile protein and mRNA corresponding to α-MHC
has been reported in the ventricular myocardium, as well as
in the atrium and sinus node (Nakao et al., 1997; Tellez et al.,
2011). Thus, Cre-recombinase would be abundantly expressed in
these tissues resulting in Serca2 deletion. Our observations are
consistent with a recent study of a cardiac specific HCN4 gene
KO mouse model wherein the α-MHC promoter linked Cre-Lox
system of gene deletion induced substantial downregulation of
HCN4 protein in the sinus node (Baruscotti et al., 2011).
In the ventricular myocardium, we found that SERCA2a
protein expression was reduced by ∼75% at 7 weeks after
tamoxifen administration. The mosaic pattern of SERCA2a
expression observed in Serca2 KO heart tissue was an interesting,
yet unexpected finding of this study. It should be borne in
mind that, conditional gene KO techniques based on excision
of lox-P-flanked DNA segments by Cre-recombinase have some
inherent pitfalls (Schmidt-Supprian and Rajewsky, 2007). LoxP-
flanked target genes differ in their sensitivity to Cre-facilitated
recombination and Cre can damage genomic DNA. Also, the
efficiency of gene KO using Cre-loxP technology is tamoxifen
dose-dependent (Schmidt-Supprian and Rajewsky, 2007; Bersell
et al., 2013). Tamoxifen administration to mice expressing
MerCreMer protein is known to induce severe, transient dilated
cardiomyopathy that is accompanied by transient reduction
in SERCA2 and phospholamban mRNA (Koitabashi et al.,
2009). Thus, data obtained immediately after tamoxifen induced
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FIGURE 7 | SERCA2a protein expression in the right atrium and sinus node. (A) Representative high magnification images showing SERCA2 labeling (green
signal) in the sinus node center (SAN C), sinus node periphery (SAN P) and atrial muscle (AM) of Serca2 FF (top row) and Serca2 KO (bottom row) right atrial tissue
sections. (B) SERCA2a fluorescence intensity in the sinus node center (SAN C), sinus node periphery (SAN P) and atrial muscle (AM) of Serca2 FF (blue bars) and
Serca2 KO (red bars) tissue sections. * denotes P < 0.05 vs. corresponding Serca2 FF tissue values.
gene inactivation, is often unreliable. In the present study,
hearts were harvested at 7 weeks post tamoxifen administration,
giving sufficient time for the transient cardiomyopathy to
resolve (Koitabashi et al., 2009). Western blot data showed
substantial reduction in SERCA2a protein content in the
left ventricular myocardium, in agreement with an earlier
study of this animal model (Andersson et al., 2009). Several
other studies have administered tamoxifen as 4–5 injections
on successive days at a safe dose (1–2 mg/day) (Danielian
et al., 1998; Andersson et al., 2009; Hougen et al., 2010;
Baruscotti et al., 2011). Our results indicate that a single dose
of tamoxifen (1 mg/day) is sufficient to induce efficient Cre-
recombination and substantial Serca2 downregulation. However,
the downregulation is heterogeneous, unlike the homogeneous
Serca2 downregulation previously observed by us in ventricular
tissue for the single dose tamoxifen injection (Hougen et al.,
2010). The single tamoxifen dose (1 mg/day) may be on the
threshold limit for efficient MerCreMer-activation (as opposed
to four injections). Thus, some cells might not be exposed
to an adequate concentration, giving rise to a mosaic pattern
of downregulation as seen elsewhere (Hayashi and McMahon,
2002).
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FIGURE 8 | Simulation of the effects of SERCA2 downregulation on the
sinus node action potential. (A) Relationship between SERCA2
downregulation (0–99% reduction) and heart rate (bpm) under various
conditions. Red symbols represent heart rates with changes to SERCA2 only
(i.e., with all other parameters unchanged). Yellow, blue and green symbols
represent introduction of changes to RyR2 (proportional to SERCA2), ICa,L
(1.3 fold increase), and INaCa (2 fold increase), respectively. The combined
effect of all changes is represented in black (SERCA2 KO remodeled). (B)
Slope of the SERCA2 KO remodeled curve. (C) Action potential profiles of
SERCA2 only (red) and SERCA2 KO remodeled (black) at 0% SERCA2
downregulation are shown. (D) Typical action potential profiles under SERCA2
only in red (top) and SERCA2 KO remodeled in black (bottom) are shown.
Solid, dashed and dotted lines represent 0, 70, and 99% SERCA2
downregulation respectively. Modeling data generated by SK.
Isolated ventricular myocytes of Serca2 KO mice show
significantly lower sarcoplasmic reticulum Ca2+ content (Swift
et al., 2008, 2012; Andersson et al., 2009; Stokke et al., 2010).
Given that we used an identical mouse model (albeit with
one tamoxifen injection instead of four), and that the SERCA2
protein is substantially downregulated, it is reasonable to expect
a significant degree of reduction in sarcoplasmic reticulum Ca2+
content in sinus node myocytes. Reduced sarcoplasmic reticulum
Ca2+ content decreases the open probability of the ryanodine
receptor and the occurrence of localized Ca2+ release events
that govern the late phase of the diastolic depolarization in the
sinus node (Bogdanov et al., 2006). Also, the kinetics of the
sarcoplasmic reticulum Ca2+ pumping by SERCA2 is known to
regulate sinus node beating rates (Vinogradova et al., 2010). In
vitro, pharmacological blockade of either the ryanodine receptor
with ryanodine or the SERCA2 pump with cyclopiazonic acid,
inhibits the sinus node beating rate (Rigg and Terrar, 1996;
Vinogradova et al., 2010; Yaniv et al., 2014). One might then ask
why the Serca2 KO mice baseline heart rates measured in vivo
(536± 31 vs. 536± 27 bpm in Serca2 FF) and sinus node beating
rates measured in vitro (431 ± 30 vs. 415 ± 16 bpm in Serca2 FF
tissues) were not different from those in Serca2 FF? In the present
study, although SERCA2a is significantly downregulated (by 70–
75%) in Serca2 KO hearts, some degree of residual SERCA2a
activity will exist and is likely to contribute to the maintenance of
baseline heart/sinus rates. Previously, we have observed baseline
bradycardia in Serca2 KO with >95% SERCA2a downregulation
and have demonstrated that very low SERCA levels are capable
of partially refilling the sarcoplasmic reticulum (Andersson et al.,
2009; Louch et al., 2010). The residual SERCA2a activity is
however, below optimal during exercise and in the presence of
adrenaline resulting in smaller heart rate increases. Additionally,
it is possible that compensatory mechanisms may have come
into play during the 7 week period to allow for the Serca2
downregulation. Blocking If slowed pacemaking that was equally
pronounced in Serca2 KO and control mice (Figure 4) and hence
it is unlikely that If compensates for the loss of the Ca
2+-clock.
It is possible that some other compensatory mechanism exists.
Pacemaking in the sinus node is also dependent on the voltage-
dependent deactivation of outward currents: the rapid and slow
delayed rectifier K+ currents (IK,r and IK,s) and activation of
inward currents such as the L- and T-type Ca2+ currents (ICa,L
and ICa,T), INaCa, tetrodotoxin-sensitive Na
+ current (INa) and
sustained inward current (Ist), amongst others (Dobrzynski et al.,
2013; Logantha et al., 2014; Morris and Kalman, 2014).
Studies on isolated ventricular myocytes of Serca2 KO
mice have shown larger ICa,L and INaCa density, indicating a
greater Ca2+-influx and extrusion across the plasma membrane
(Andersson et al., 2009). Using mathematical modeling, we
evaluated the consequences of increased ICa,L and INaCa on
the heart rate of Serca2 KO. Downregulation of SERCA2 alone
caused a reduction in heart rate that was pronounced at >70%
SERCA2 downregulation. At >95% SERCA2 downregulation,
pacemaking was arrhythmic, i.e., non-periodic. When SERCA2
downregulation was coupled with a proportional reduction
of Ca2+ flux through the RyR2, the region of arrhythmic
pacemaking was increased. This is in agreement with our
previous work, as well as work by others (Kharche et al., 2011;
Maltsev and Lakatta, 2013). As the membrane- and Ca2+-
clocks in our model are based on extensive experimental data,
it was possible to simulate the phenomenon of how SERCA2
alterations affect heart rate. In the sinus node model, ICa,L
regulates the upstroke of the action potential and the heart
rate (Kharche et al., 2011). On the other hand, INaCa mainly
provides calcium homeostasis. Therefore, in the current study,
increasing ICa,L increased the heart rate and INaCa augmentation
resulted in lower heart rate measurements due to a lower level
of cytosolic Ca2+. Simultaneously altering multiple parameters
(conductance of SERCA2, RyR2, ICa,L, and INaCa) does not result
in a straightforward overlay of the outcomes (i.e., heart rates)
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because the cell model is complex and non-linear (Kharche
et al., 2009). Implementing the remodeling as a simultaneous
change of function in RyR2, ICa,L, and INaCa resulted in
reduced heart rates. The heart rate changes minimally upto 70%
SERCA2 downregulation; however, at >70% downregulation the
reduction in heart rate is much pronounced. This is consistent
with our experimental observations and it is likely that similar
compensatory remodeling occurs in the sinus node which helps
maintain baseline heart rate in vivo and in vitro. Although,
mathematical models cannot encompass all the physiological
processes in a sinus node cell, our model is capable of dissecting
the important mechanisms that regulate pacemaking (See Model
Limitations in Supplementary Material).
In vivo, with the sympathetic innervation intact, the resting
heart rates of both Serca2 KO and Serca2 FF mice are higher
than that observed in vitro in isolated right atrial preparations.
In our study, Serca2 KO mice with 75% reduction in left
ventricular SERCA2a protein content show a smaller increase in
heart rate vs. Serca2 FF in response to exercise and adrenaline
injection. This is consistent with the smaller increase in heart
rate in response to isoproterenol observed in Serca2 KO mice
with >95% SERCA2a downregulation (Boardman et al., 2014).
Catecholamine mediated acceleration of sinus node pacemaking
is crucially dependent on the Ca2+-clock (Gao et al., 2010;
Lakatta et al., 2010; Liu et al., 2011).
The ECG PR-interval, a measure of AV node conduction,
was significantly prolonged in Serca2 KO mice. In the present
study, we also show that ryanodine, by disrupting sarcoplasmic
reticulum Ca2+ releases, prolongs the AH-interval and the
Wenckebach cycle length in isolated rat AV node preparations.
This is consistent with previous work from our laboratory
that showed that ryanodine increases the spontaneous cycle
length of intact AV node preparations (Nikmaram et al.,
2008). Additionally, both ryanodine and SERCA inhibitors
(thapsigargin and cyclopiazonic acid) prolong the spontaneous
cycle length in isolated AV node myocytes and the beating rate is
therefore dependent on sarcoplasmic reticulum function (Ridley
et al., 2008; Cheng et al., 2011). The prolonged PR-interval in
Serca2 KO mice is indicative of first degree AV-block and points
at the important role for sarcoplasmic reticulum Ca2+ in AV
node function.
CLINICAL PERSPECTIVES AND FUTURE
APPLICATIONS
SERCA2 is an important Ca2+ handling protein in the sinus
node. Serca2 expression as well as protein abundance is
significantly altered in the diseased or aged sinus node (Tellez
et al., 2011; Benoist et al., 2014). It has been long established that
SERCA2a expression and activity is decreased in human heart
failure of most etiologies and SERCA2a is a promising target for
gene therapy in heart failure (Unverferth et al., 1988; Mercadier
et al., 1990; Hasenfuss et al., 1994; Bers et al., 2003; Hayward
et al., 2014). However, it has not been clear whether Serca2 loss
is a basis for or a result of sinus node disease and heart failure.
Here we show for the first time that Serca2 downregulation can
cause pacemaker dysfunction, which might contribute to further
deterioration in an already failing heart. The Serca2 KO mouse
developed for this study is a valuable tool in the investigation
of the role of the sarcoplasmic reticulum in sinus node and AV
node function. Previously, such investigations were limited by
the use of pharmacological tools to block the SERCA2 pump
or ryanodine receptor. The Serca2 KO mouse offers a suitable
platform for mechanistic studies at the level of the single cell,
tissue and the whole animal.
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